Ibacitabine
Ibacitabine
|
Names |
IUPAC name
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one |
Identifiers |
ATC code |
D06BB08 |
|
611-53-0 Y |
ChemSpider |
58561 N |
InChI=1S/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1 NKey: WEVJJMPVVFNAHZ-RRKCRQDMSA-N NInChI=1/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1 Key: WEVJJMPVVFNAHZ-RRKCRQDMBC
|
Jmol-3D images |
Image |
KEGG |
D07200 Y |
PubChem |
65050 |
IC=1\C(=N/C(=O)N(C=1)[C@@H]2O[C@@H]([C@@H](O)C2)CO)\N
|
Properties |
|
C9H12IN3O4 |
Molar mass |
353.11375 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
N verify (what is: Y/N?) |
Infobox references |
|
|
Ibacitabine (or ibacitabin,[1] or 5-iodo-2'-deoxycytidine ) is an antiviral drug.
References
- ↑ "[Contact dermatitis to topical antiviral drugs]". Ann Dermatol Venereol 127 (2): 191–3. February 2000. PMID 10739980.
External links
Antibiotics and chemotherapeutics for dermatological use ( D06) |
---|
| Antibiotics | |
---|
| Chemotherapeutics | |
---|
| |
---|
| Description |
- Anatomy
- Physiology
- Development
|
---|
| Disease |
- Infections
- Vesiculobullous
- Dermatitis and eczema
- Papulosquamous
- Urticaria and erythema
- Radiation-related
- Pigmentation
- Mucinoses
- Keratosis, ulcer, atrophy, and necrobiosis
- Vasculitis
- Fat
- Neutrophilic and eosinophilic
- Congenital
- Neoplasms and cancer
- nevi and melanomas
- epidermis
- dermis
- Symptoms and signs
- Terminology
|
---|
| Treatment |
- Procedures
- Drugs
- antibiotics
- disinfectants
- emollients and protectives
- itch
- psoriasis
- other
- Wound and ulcer
|
---|
|
|